|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM072321660 |
| 003 |
DE-627 |
| 005 |
20231222013951.0 |
| 007 |
tu |
| 008 |
231222s1981 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0241.xml
|
| 035 |
|
|
|a (DE-627)NLM072321660
|
| 035 |
|
|
|a (NLM)7255510
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Nenci, G G
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Effect of pentoxifylline on platelet aggregation
|
| 264 |
|
1 |
|c 1981
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 25.09.1981
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The effect of various concentrations of pentoxifylline, a methylxanthine, on platelet aggregation was evaluated in vitro by Born's method. The study was performed on platelet-rich plasma obtained from two series of clinically healthy subjects: in the first, pentoxifylline was added to platelet-rich plasma just before ADP or epinephrine; in the second, pentoxifylline was incubated with platelet-rich plasma for 150 minutes at 37 degrees C before testing. Statistical analysis of the results demonstrates that pentoxifylline exerts a dose-dependent inhibiting action on platelet aggregation, particularly when epinephrine is chosen as the aggregating agent, and that the pre-incubation of pentoxifylline with blood platelets greatly enhances its inhibitory effect
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Adenosine Diphosphate
|2 NLM
|
| 650 |
|
7 |
|a 61D2G4IYVH
|2 NLM
|
| 650 |
|
7 |
|a Theobromine
|2 NLM
|
| 650 |
|
7 |
|a OBD445WZ5P
|2 NLM
|
| 650 |
|
7 |
|a Pentoxifylline
|2 NLM
|
| 650 |
|
7 |
|a SD6QCT3TSU
|2 NLM
|
| 650 |
|
7 |
|a Epinephrine
|2 NLM
|
| 650 |
|
7 |
|a YKH834O4BH
|2 NLM
|
| 700 |
1 |
|
|a Gresele, P
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Agnelli, G
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ballatori, E
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
|d 1995
|g 2(1981), 8 vom: 16., Seite 532-8
|w (DE-627)NLM023961570
|
| 773 |
1 |
8 |
|g volume:2
|g year:1981
|g number:8
|g day:16
|g pages:532-8
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2
|j 1981
|e 8
|b 16
|h 532-8
|